Healthcare -
Biotechnology - NASDAQ - US
$ 6.18
10.8 %
$ 55.9 M
Market Cap
-153.5
P/E
ICCC - LONG-TERM DEBT
Long-term Debt ICCC - ImmuCell Corporation
13.2 M
LAST VALUE
7.44%
2 YEAR CAGR
13.00%
5 YEAR CAGR
33.26%
10 YEAR CAGR